# Evidium

Evidium is an Asset Manager based in Louisville, United States.

## Overview

- **Organization type:** Asset Manager
- **Headquarters:** Louisville, United States
- **Region:** North America
- **Address:** Louisville, Chicago, San Diego, Chapel Hill, Menlo Park, San Francisco, Portsmouth, United States
- **Assets under management:** Undisclosed
- **Website:** evidium.com
- **LinkedIn:** https://www.linkedin.com/company/evidium

## Regulatory record

- **Reports private funds:** No

## About

Evidium is a neuro-symbolic AI platform provider founded in 2021 in San Francisco, California. Their services include clinical workflow transformation, organizational analytics improvement, and infrastructure for knowledge dissemination. Evidium serves health systems, insurers, and pharmaceutical companies with applications based on ontology and knowledge graphs.

## Sectors

- Digital Health
- AI/ML

## Questions

### What is Evidium's core product?

Evidium builds world models for healthcare — computational representations of clinical states and disease progression. The platform projects patient trajectories over a map of conditions and the transitions between them, enabling payers and providers to forecast severity, cost trajectories, and intervention outcomes.

### How does Evidium's approach differ from generative AI or LLM-based healthcare tools?

The firm explicitly distinguishes its Computational Medical Intelligence from generative AI. While LLMs discuss medical knowledge, Evidium computes the dynamics of disease progression. Its model is built on causal maps of clinical states and transitions, grounding every insight in traceable clinical evidence and real-world events rather than probabilistic text generation.

### Who backs Evidium?

Evidium's disclosed investors include Health2047, the venture studio of the American Medical Association; WGG Partners, a specialist deep-tech fund with early-stage backing of x.AI and Perplexity; PGV; Interwoven Ventures; and Mindset Ventures, alongside other specialist funds and individuals, per the firm's website.

### Which end-markets does Evidium serve?

The platform is designed for four segments: self-insured employers seeking cost-trajectory forecasting, health plans managing population risk and pricing, hospitals and health systems coordinating longitudinal treatment, and research organizations modeling therapeutic impact and real-world evidence.

### Does Evidium make direct clinical recommendations?

The firm states its models support, rather than replace, expert judgment. Insights are designed to inform clinical and financial decisions by making disease dynamics computationally visible, with each projection traced to underlying clinical evidence.

## Related profiles

- [SiteBridge Research](https://altss.com/profile/sitebridge-research)
- [WaterRower](https://altss.com/profile/waterrower)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/evidium

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology